Detalhe da pesquisa
1.
SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.
Prostate
; 81(16): 1267-1277, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34533858
2.
SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer.
Prostate
; 79(10): 1156-1165, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31090082
3.
CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.
Histopathology
; 72(2): 259-269, 2018 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28795418
4.
Dual mTOR1/2 Inhibitor Sapanisertib (FTH-003/TAK-228) in Combination With Weekly Paclitaxel in Patients With Previously Treated Metastatic Urothelial Carcinoma: A Phase II Open-Label Study.
Clin Genitourin Cancer
; 22(5): 102123, 2024 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38905731
5.
The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer.
Sci Rep
; 13(1): 15287, 2023 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37714872
6.
Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer.
Virchows Arch
; 2023 Nov 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38017230
7.
Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
Sci Rep
; 10(1): 20135, 2020 11 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33208770
8.
Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.
Virchows Arch
; 475(2): 223-231, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31209634
9.
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.
Virchows Arch
; 475(4): 457-466, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31016435
10.
FOXO1 down-regulation is associated with worse outcome in bladder cancer and adds significant prognostic information to p53 overexpression.
Hum Pathol
; 62: 222-231, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28087474
11.
ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.
Oncotarget
; 8(43): 74106-74118, 2017 09 26.
Artigo
Inglês
| MEDLINE | ID: mdl-29088771
12.
NOTCH2 mutations in marginal zone lymphoma.
Haematologica
; 93(7): 1107-9, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18508802